dimethylmyleran has been researched along with Hepatic Veno Occlusive Disease in 2 studies
dimethylmyleran: RN given refers to cpd without isomeric designation
dimethylmyleran : A methanesulfonate ester that is hexane-2,5-diol in which the hydrogens of the hydroxy groups are replaced by methanesulfonyl groups.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shulman, HM | 2 |
Luk, K | 1 |
Deeg, HJ | 1 |
Shuman, WB | 1 |
Storb, R | 2 |
Kanfer, EJ | 1 |
Buckner, CD | 1 |
Fefer, A | 1 |
Appelbaum, FR | 1 |
Hill, RS | 1 |
Amos, D | 1 |
Doney, KC | 1 |
Clift, RA | 1 |
2 other studies available for dimethylmyleran and Hepatic Veno Occlusive Disease
Article | Year |
---|---|
Induction of hepatic veno-occlusive disease in dogs.
Topics: Animals; Busulfan; Buthionine Sulfoximine; Cyclophosphamide; Disease Models, Animal; Dog Diseases; D | 1987 |
Allogeneic and syngeneic marrow transplantation following high dose dimethylbusulfan, cyclophosphamide and total body irradiation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; | 1987 |